Northstar Asset Management LLC Sells 930 Shares of Thermo Fisher Scientific Inc (TMO)

Northstar Asset Management LLC decreased its position in Thermo Fisher Scientific Inc (NYSE:TMO) by 2.6% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 35,430 shares of the medical research company’s stock after selling 930 shares during the period. Thermo Fisher Scientific makes up 2.8% of Northstar Asset Management LLC’s portfolio, making the stock its 6th largest position. Northstar Asset Management LLC’s holdings in Thermo Fisher Scientific were worth $6,181,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently bought and sold shares of the company. Proficio Capital Partners LLC raised its position in shares of Thermo Fisher Scientific by 71.5% in the first quarter. Proficio Capital Partners LLC now owns 607 shares of the medical research company’s stock worth $105,000 after buying an additional 253 shares during the last quarter. Cribstone Capital Management LLC raised its position in shares of Thermo Fisher Scientific by 8.7% in the second quarter. Cribstone Capital Management LLC now owns 625 shares of the medical research company’s stock worth $109,000 after buying an additional 50 shares during the last quarter. Independent Portfolio Consultants Inc. raised its position in shares of Thermo Fisher Scientific by 0.3% in the first quarter. Independent Portfolio Consultants Inc. now owns 730 shares of the medical research company’s stock worth $112,000 after buying an additional 2 shares during the last quarter. Sharkey Howes & Javer raised its position in shares of Thermo Fisher Scientific by 1.0% in the first quarter. Sharkey Howes & Javer now owns 733 shares of the medical research company’s stock worth $113,000 after buying an additional 7 shares during the last quarter. Finally, CWM LLC raised its position in shares of Thermo Fisher Scientific by 17.0% in the second quarter. CWM LLC now owns 710 shares of the medical research company’s stock worth $124,000 after buying an additional 103 shares during the last quarter. 87.15% of the stock is currently owned by institutional investors and hedge funds.

Thermo Fisher Scientific Inc (NYSE:TMO) traded up 1.15% during midday trading on Friday, hitting $173.72. 651,833 shares of the stock traded hands. The firm’s 50-day moving average is $176.85 and its 200-day moving average is $165.24. The company has a market cap of $67.77 billion, a price-to-earnings ratio of 30.26 and a beta of 1.06. Thermo Fisher Scientific Inc has a 52-week low of $139.07 and a 52-week high of $182.87.

Thermo Fisher Scientific (NYSE:TMO) last released its quarterly earnings data on Wednesday, July 26th. The medical research company reported $2.30 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.27 by $0.03. Thermo Fisher Scientific had a net margin of 11.80% and a return on equity of 15.97%. The company had revenue of $5 billion during the quarter, compared to analyst estimates of $4.92 billion. During the same period in the prior year, the firm earned $2.03 earnings per share. The firm’s revenue for the quarter was up 10.2% compared to the same quarter last year. Analysts predict that Thermo Fisher Scientific Inc will post $9.24 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, October 16th. Investors of record on Friday, September 15th will be paid a $0.15 dividend. This represents a $0.60 dividend on an annualized basis and a yield of 0.35%. The ex-dividend date of this dividend is Thursday, September 14th. Thermo Fisher Scientific’s dividend payout ratio (DPR) is presently 10.45%.

WARNING: “Northstar Asset Management LLC Sells 930 Shares of Thermo Fisher Scientific Inc (TMO)” was first reported by Community Financial News and is the sole property of of Community Financial News. If you are viewing this news story on another site, it was illegally copied and reposted in violation of United States & international copyright legislation. The correct version of this news story can be viewed at https://www.com-unik.info/2017/08/11/northstar-asset-management-llc-sells-930-shares-of-thermo-fisher-scientific-inc-tmo.html.

TMO has been the topic of several recent research reports. Cantor Fitzgerald initiated coverage on shares of Thermo Fisher Scientific in a report on Thursday, May 18th. They set an “overweight” rating and a $194.00 target price on the stock. Barclays PLC set a $175.00 target price on shares of Thermo Fisher Scientific and gave the company a “buy” rating in a report on Wednesday, April 26th. Cowen and Company reaffirmed an “outperform” rating and set a $185.00 target price (up previously from $175.00) on shares of Thermo Fisher Scientific in a report on Saturday, April 29th. Citigroup Inc. reaffirmed a “buy” rating and set a $201.00 target price (up previously from $182.00) on shares of Thermo Fisher Scientific in a report on Monday, July 10th. Finally, BidaskClub raised shares of Thermo Fisher Scientific from a “buy” rating to a “strong-buy” rating in a report on Tuesday, July 11th. One equities research analyst has rated the stock with a hold rating, sixteen have issued a buy rating and one has given a strong buy rating to the company. Thermo Fisher Scientific has an average rating of “Buy” and an average target price of $188.56.

In related news, insider Daniel P. Shine sold 4,688 shares of the company’s stock in a transaction dated Wednesday, May 24th. The shares were sold at an average price of $171.88, for a total value of $805,773.44. Following the completion of the sale, the insider now directly owns 29,200 shares of the company’s stock, valued at $5,018,896. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CEO Marc N. Casper sold 20,000 shares of the company’s stock in a transaction dated Thursday, June 1st. The stock was sold at an average price of $172.79, for a total transaction of $3,455,800.00. Following the completion of the sale, the chief executive officer now directly owns 269,279 shares of the company’s stock, valued at $46,528,718.41. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 27,188 shares of company stock valued at $4,702,223. 0.49% of the stock is owned by insiders.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

What are top analysts saying about Thermo Fisher Scientific Inc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Thermo Fisher Scientific Inc and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit